| abstract |
PHARMACEUTICAL COMPOSITION A b s t r a c t The invention relates to the use of 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione (generic name: pentoxifylline) and/or 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophylline-7-acetate (Depogen) or monohydrate thereof for preparing a pharmaceutical composition suitable for improving the tissue antioxidant status. This status plays an im-portant role in complications, occurring as a con-sequence of pathologically developed or artificially established anastomoses, particularly anastomosis of oesophagus and colon since these organs possess a very weak antioxidant protective system. The invention furthermore relates to the preparation of the above pharmaceutical compositions. The above active ingredients promote and accelerate the healing process of anastomoses by improving the tissue antioxidant status and besides, they retain their good inhibitory effect on the adhesion of anastomoses. |